These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34886135)
1. Inhaled Drug Therapy-Associated Adverse Reactions in Obstructive Respiratory Diseases: A Review of a Decade of Reporting to the Portuguese Pharmacovigilance System. Fonseca W; Monteiro C; Taborda-Barata L Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886135 [TBL] [Abstract][Full Text] [Related]
2. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese pharmacovigilance system. Monteiro C; Duarte AP; Alves G Expert Opin Drug Saf; 2021 Jan; 20(1):109-118. PubMed ID: 33170742 [No Abstract] [Full Text] [Related]
4. Biological therapy-associated adverse reactions in asthma: analysis of reporting to the Portuguese pharmacovigilance system. Sousa J; Taborda-Barata L; Monteiro C Expert Opin Drug Saf; 2020 Jan; 19(1):99-106. PubMed ID: 31661986 [No Abstract] [Full Text] [Related]
5. Assessment of suspected adverse drug reactions in elderly patients with diabetes mellitus based on a Portuguese spontaneous reporting database: analysis of reporting from 2008 to 2018. Monteiro C; Silvestre S; Duarte AP; Alves G Expert Opin Drug Saf; 2021 Jul; 20(7):845-853. PubMed ID: 33962523 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis. Mendes D; Oliveira AR; Alves C; Batel Marques F Expert Opin Drug Saf; 2020 Jun; 19(6):763-769. PubMed ID: 32167395 [TBL] [Abstract][Full Text] [Related]
7. Paediatric adverse drug reactions following use of asthma medications in Europe from 2007 to 2011. Aagaard L; Hansen EH Int J Clin Pharm; 2014 Dec; 36(6):1222-9. PubMed ID: 25288145 [TBL] [Abstract][Full Text] [Related]
8. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database. Cutroneo PM; Arzenton E; Furci F; Scapini F; Bulzomì M; Luxi N; Caminati M; Senna G; Moretti U; Trifirò G BioDrugs; 2024 May; 38(3):425-448. PubMed ID: 38489062 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
10. Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit. Salvador MR; Monteiro C; Pereira L; Duarte AP Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409436 [TBL] [Abstract][Full Text] [Related]
11. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
12. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study. Monteiro C; Dias B; Vaz-Patto M Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926 [TBL] [Abstract][Full Text] [Related]
13. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248 [TBL] [Abstract][Full Text] [Related]
14. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study. Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands. Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243 [TBL] [Abstract][Full Text] [Related]
16. Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database. Gustafsson M; Matos C; Joaquim J; Scholl J; van Hunsel F Drug Saf; 2023 Nov; 46(11):1133-1148. PubMed ID: 37824028 [TBL] [Abstract][Full Text] [Related]
17. Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System. Monteiro C; Silvestre S; Duarte AP; Alves G Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329224 [TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years. Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417 [TBL] [Abstract][Full Text] [Related]
19. The importance of monitoring adverse drug reactions in elderly patients: the results of a long-term pharmacovigilance programme. Carnovale C; Gentili M; Fortino I; Merlino L; Clementi E; Radice S; ViGer Group Expert Opin Drug Saf; 2016; 15(2):131-9. PubMed ID: 26882049 [TBL] [Abstract][Full Text] [Related]
20. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]